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Abstract
Assessing the impact that patterns of Na intake may have on gastric cancer will provide a more comprehensive estimation of Na reduction as a
primary prevention approach. We aimed to estimate the proportion of gastric cancer cases that are attributable to Na intake above the
recommendation by the WHO (≤2 g/d) throughout the world in 2010, as well as expected values for 2030. Population attributable fractions
(PAF) were computed for 187 countries, using Na intakes in 1990 and 2010 and estimates of the association between Na intake and gastric
cancer, assuming a time lag of 20 years. Median PAF ranged from 10·1% in low to 22·5% in very high Human Development Index (HDI)
countries in men (P< 0·001) and from 7·2 to 16·6%, respectively, among women (P< 0·001). An increase in median PAF until 2030 is expected
in most settings, except for countries classiﬁed as low HDI, in both sexes. High Na intakes account for a large proportion of gastric cancer
cases, and proportions are expected to increase in almost all of the countries. Intensiﬁed efforts to diminish Na intake in virtually all
populations are needed to further reduce gastric cancer burden.
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Gastric cancer is the ﬁfth most common malignancy and the
third leading cause of cancer death worldwide(1), despite the
sustained decline in gastric cancer rates over the past
several decades(2,3). The apparent potential for an even greater
decrease without speciﬁc interventions to control its main
determinants contributes to the misperception that gastric can-
cer may no longer be an important public health concern,
at least in more developed countries. However, in the most
recent years, the relative declines were smaller in several
settings, and a levelling off is already expected in a few
countries(4).
Na intake was one of the ﬁrst exposures to be associated with
gastric cancer(5–7) and gastric pre-cancerous lesions(8,9). Among
all cancers, Na intake was found to be associated only with
gastric cancer(7), with high Na intake increasing the risk by
approximately two-fold(10,11).
Worldwide, increases in Na intake between 1990 and 2010
have been reported(12), with consumption in 2010 exceeding
the recommended levels in almost all countries. In fact, the
global mean Na intake (3·95 g/d) was nearly twice the WHO-
recommended limit (2 g/d).
Given the high intakes of Na and the increasing trends
observed at an international level, assessing the impact that
these patterns of exposure may have on gastric cancer will
provide data for a more comprehensive estimation of the
impact of Na reduction as a primary prevention approach.
Therefore, we aimed to estimate the population attributable
fraction (PAF) for gastric cancer in 2010 that could be due to Na
intake above the WHO recommendation throughout the world
in 1990, and the corresponding ﬁgures expected for 2030 based
on exposures in 2010.
Methods
PAF, that is, estimates of the proportion of gastric cancer cases
that could be attributed to Na intake above the WHO recom-
mendation (≤2 g/d)(13), were computed for different countries.
Abbreviations: HDI, Human Development Index; PAF, population attributable fraction; RR, relative risk.
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We used country-speciﬁc data on Na intake and published
estimates of the magnitude of the association between Na
intake and gastric cancer. A time lag of 20 years was assumed
on the basis of the similar magnitude of the association between
Na intake and cancer(10) and intestinal metaplasia(9), which is in
accordance with the model for the progression of gastric cancer
proposed by Correa(8).
Association between sodium intake and gastric cancer
We conducted a systematic review of meta-analyses to obtain
estimates of the magnitude of association between Na intake
and gastric cancer. A total of eighty-eight references were
retrieved through a PubMed search, from inception to May
2015, and backward citation tracking. Full papers published in
English, Portuguese, Spanish, French, Italian and Polish were
evaluated. Articles not reporting the results of meta-analyses, of
Na or salt intake as an exposure, of gastric cancer as an
outcome or not performing a quantitative evaluation of the
association between Na or salt intake and gastric cancer were
excluded. Screening of reference lists and data extraction were
accomplished independently by two researchers (B. P., C. C.),
following a protocol deﬁned a priori, and discrepancies were
discussed until consensus or were resolved involving a third
researcher (N. L.); ﬁve meta-analyses fulﬁlling the criteria were
identiﬁed(7,10,11,14,15). A detailed description of the published
meta-analyses is provided in the online Supplementary Table S1
and results in Fig. 1.
Only one meta-analysis presented the results for Na (rather
than salt) intake(7), reporting a 1·14 increased risk per 1 g/d
increment in Na intake.
Sodium intake
Mean levels of Na intake in 1990 and in 2010 by sex for 187
countries were retrieved from the Global Sodium Consumption
Study(12). It included published and unpublished data from 142
surveys of 24-h urinary Na and 103 of dietary Na conducted
between 1980 and 2010 across sixty-six countries; a Bayesian
model was used to convert dietary values into comparable 24-h
urine values, and mean Na intake (g/d) was estimated without
adjustment for non-urinary losses.
Calculation of population attributable fractions
We estimated the proportional reduction in gastric cancer
incidence that would arise if exposure to Na corresponded to a
counterfactual scenario, deﬁned as the exposure that would
result in the lowest population risk (e.g. a population in which
no one exceeded the WHO reference value of ≤2 g/d of Na
intake). We used the method proposed by Levin(16) but applied
to a continuous exposure(17):
PAF =
PðRR1Þ
P RR1ð Þ + 1=
eðcoefficient ´differenceÞ1
eðcoefficient ´ differenceÞ
;
where coefﬁcient is the logarithmic coefﬁcient of the relative
risk (RR) of the association between Na intake and gastric
cancer per unit of increment in Na intake, and difference is the
difference between the mean level of Na intake in each country
and the WHO recommendation. From our systematic review,
we obtained an estimate of the RR per unit of increment in Na
intake, 1·14 per 1 g/d, equivalent to a logarithmic coefﬁcient
of 0·131.
.
.
.
.
Per 1 g/d increment in Na intake
WCRF
Highest v. lowest Na intake
WCRF
Per 1 g/d increment in salt intake
WCRF
Highest v. lowest salt intake
WCRF
D’Elia
Ge
Bonequi
Woo
Author
2007
2007
2007
2007
2012
2012
2013
2014
Year
World
World
World
World
World
World
Latin America
Korea
Setting
1.45 1.07, 1.98
2.05 1.60, 2.62
All studies
All studies
1.14 1.00, 1.30
2.03 0.91, 4.52
1.03 1.00, 1.06
1.68 1.17, 2.41
2.24 1.53, 3.29
1.92 1.52, 2.43
RR 95 % CI
All studies
All studies
All studies
Cohort
Case–control
All studies
Design
10.7 2 5
Fig. 1. Meta-analyses on the association between sodium or salt intake and gastric cancer. Meta-analyses identified through a PubMed search, from inception to May
2015, using the following expression: (gastric OR stomach) AND cancer AND (salt OR salted OR salty OR food OR sodium) AND (‘systematic review’ OR
meta-analysis OR ‘combined analysis’ OR ‘pooled analysis’).
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Estimates of PAF due to Na intake above the WHO recom-
mendation in each country were computed for 2010 and 2030, for
those with available Na intake estimates for 1990 and 2010,
respectively. We multiplied each value by 100 to obtain PAF esti-
mates in percentage. In countries where mean Na intake was
below the WHO recommendation, PAF estimates were set to 0·0%.
PAF was treated as a continuous variable, and comparisons
across sexes, time periods and regions were made using the
Kruskal–Wallis test because of a non-normal distribution.
Results
There were wide geographical differences in PAF in 2010 and
2030 (Fig. 2 and online Supplementary Tables S2 and S3).
Regardless of sex and time period, PAF estimates were higher in
Asian regions, particularly in eastern and south-eastern Asia,
and in Europe, mainly in central and eastern Europe. The
lowest estimates of PAF were observed in Africa, especially in
eastern Africa. Between 2010 and 2030, we observed, for most
countries, an increase in the proportion of gastric cancer cases
that could be attributed to Na intake above the WHO recom-
mendation of ≤2 g/d in both sexes.
Fig. 3 depicts the distribution of PAF estimates according to the
level of Human Development Index (HDI) of the country in
2010(18). Signiﬁcantly higher median PAF estimates were
observed in men compared with women in both years in all
geographic regions and across levels of HDI. Median PAF esti-
mates increased with HDI (P< 0·001), ranging from 10·1% in
those with low HDI to 22·5% in those with very high HDI in men
and from 7·2 to 16·6%, respectively, in women. Countries for
which no HDI evaluation was available presented median PAF
similar to the ones observed in low-HDI countries (10·3% in men
and 7·3% in women). For countries in all HDI groups, we
observed a signiﬁcant increase in the median proportion of cases
attributable to high Na intake until 2030, except for countries
classiﬁed as low HDI, in both sexes. Nevertheless, in all countries
meeting the WHO recommendation for Na intake (≤2 g/d) in
1990, the PAF estimates remained zero in 2030, except for men
in Jamaica (online Supplementary Tables S2 and S3).
Discussion
Na intake above the reference level recommended by the WHO
(2 g/d) is responsible for an important share of the gastric
cancer burden worldwide. The proportion of gastric cancer
cases that can be attributed to high Na intake differs
substantially across countries with different levels of develop-
ment, as expected, due to regional differences in Na intake.
To our knowledge, this is the ﬁrst study computing the
proportion of gastric cancer cases that could be attributed to Na
intake above the WHO recommendation (≤2 g/d), at the
international level. Previous analyses addressing the global
effect of Na intake were mostly focused on CVD, via hyper-
tension(19). However, at the regional level, one study has
performed a similar analysis in the UK(20). Compared with our
study, higher values in men (30·9 v. 20·5%) and lower values in
women (12·1 v. 14·6%) were reported for gastric cancer cases
diagnosed in 2010 in the UK. A few differences in the way the
analysis was conducted may account for these disparities –
namely, the use of a lower RR estimate (1·08 v. 1·14 per 1 g/d)
and a higher recommended maximum level for Na intake (2·4 v.
2 g/d) contributed to lower estimates of PAF. On the contrary,
the higher mean Na intakes (4·40 v. 3·75 g/d in men and 3·24 v.
3·21 g/d in women) used in their calculations led to higher
estimates of PAF. Nevertheless, they assumed a latent period
based on the duration of follow-up in the two studies con-
tributing to the pooled RR value used in their study, which was
shorter than the one we presumed (10 v. 20 years), precluding a
direct comparison between estimates. Since this study was
published, one meta-analysis of prospective studies(10),
including the previous two and ﬁve additional ones, found
relatively stronger associations in those with a follow-up of 10
or more years. In addition, we considered the results of a meta-
analysis addressing the association between Na consumption
and intestinal metaplasia, showing a magnitude of the asso-
ciation similar to the one observed for gastric cancer as an end
point(9). Taking into account the model for the progression of
gastric cancer proposed by Correa(8), which shows a 30–50-year
duration in the process between gastric atrophy to cancer, the
20 years time lag assumed in our analysis seems to be more
plausible, which is expected to contribute to more accurate
estimates of PAF in our study.
Our results show variation according to sex, with 18 and 14%
of gastric cancer cases in 2010 being attributed to high Na intake
in men and women, respectively. These differences were
observed across countries with different levels of HDI and
regardless of the time period, and they mainly reﬂect the differ-
ence in mean Na intakes observed between sexes. Nevertheless,
the accuracy of our estimates of PAF could have been improved
if sex-speciﬁc summary RR were also available, but studies pro-
viding information for gastric cancer risk associated with Na
intake stratiﬁed by sex are scarce(7), and no signiﬁcant differences
were reported in subgroup analyses for the relationship between
categories of Na intake and risk of gastric cancer(10,11).
The burden of gastric cancer attributable to Na intake above
the WHO recommendation also differs according to the socio-
economic status at country level, which is higher in more
developed countries compared with those less developed.
However, much lower gastric cancer PAF are observed in
countries with low HDI and there was no meaningful variation
between 2010 and 2030, which is in accordance with Na intakes
near the recommended level in these settings(12) and relatively
stable levels of intake between 1990 and 2010, respectively.
Following the marked differences in Na intake identiﬁed
across regions, Asia presented the highest PAF in both periods
due to the peak levels of Na intake observed in this continent in
1990 and the largest increase until 2010. On the contrary,
African countries presented the lowest mean Na intakes by sex,
with virtually no changes between 1990 and 2010, and therefore
the lowest PAF estimates were observed in this setting.
Nevertheless, the attributable gastric cancer burden in some
geographic regions may be underestimated because of less
reliable estimates of Na intake. Although the surveys used to
estimate national Na intakes covered 74% of the global adult
population, only 35% were nationally representative(12).
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Fig. 2. Estimates of population attributable fractions (%) for gastric cancer in 2010 and 2030 (quartiles of the distributions in 2010 and in 2030 were used as cut-offs)
as a result of sodium intake above the WHO recommendation (≤2 g/d) in 187 countries by sex in 1990 and 2010, respectively. Men 2010: , no data; , 0·0–10·3; ,
10·4–17·8; , 17·9–23·1; , 23·2–37·8. Men 2030: , no data; , 0·0–10·9; , 11·0–19·4; , 19·5–25·9; , 26·0–43·1. Women 2010: , no data; , 0·0–7·3; ,
7·4–14·3; , 14·4–18·7; , 18·8–33·2. Women 2030: , no data; , 0·0–7·6; , 7·7–15·9; , 16·0–22·0; , 22·1–38·4.
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Differences in mean Na intakes across countries from 1990 to
2010 represent the net result of potentially large reductions in
Na intakes over time(6), consistent with changes in the tradi-
tional methods of food preservation made possible by the
widespread availability of domestic refrigeration, and the recent
increase in the global consumption of highly processed
foods(21), countering or even reversing these historical asso-
ciations between modernisation and declining Na intakes.
Therefore, upward trends in Na intakes have been observed
worldwide(12), which explain the predicted increase in PAF
from 2010 to 2030 in most settings. Nevertheless, in the few
countries where a decline in PAF was observed during this
period, this may be insufﬁcient to overcome the increase in the
number of cases due to population growth and ageing(22).
However, accurate estimates of the future attributable disease
burden can only be obtained when predictions take into
account the latest observed trends in gastric cancer incidence
and the projected changes in population structure.
The assumptions underlying valid estimation of PAF include a
causal relationship between exposure and disease and that
unbiased and free from confounding RR estimates are available
for the relation between the exposure and the outcome.
Regarding the evidence of a causal role of Na in gastric
carcinogenesis, this has already been pointed out as a major
component of the causal mechanisms leading to gastric
cancer(8). In 1997, the World Cancer Research Fund classiﬁed
Na as a probable cause of gastric cancer(23), which was further
conﬁrmed in its updated report in 2007(7). This evaluation was
based on cohort, case–control and ecological studies conducted
in various parts of the world showing a consistent association
between Na intake and gastric cancer, and also presented data
regarding a dose–response relationship and the effect on
pre-malignant conditions. Most of the studies included in these
reviews of the evidence presented RR estimates adjusted for
sex, age, Helicobacter pylori infection status, smoking status
and other dietary factors – namely, the consumption of fruits
and vegetables. Although residual confounding cannot be ruled
out, it is unlikely that control for the effects of potentially major
confounders has not been accomplished. For the present study,
we used the best available evidence on the association between
Na intake and gastric cancer, obtained from the dose–response
meta-analysis published in the second expert report(7), which
included cohort and case–control studies. However, summary
estimates are higher if only retrieved only from case–control
studies (RR 1·18 per 1 g/d increment in Na intake; 95% CI 1·02,
1·38(7)). This may have contributed to a conservative bias in our
estimates of PAF, although not compromising the comparison
across regions. In addition, no signiﬁcant differences in the
association between Na intake and gastric cancer according to
tumour location or histological type have been described(7),
contributing to the accuracy of our estimates of the gastric
cancer burden attributable to high Na intake.
The estimates of Na intake used in our study came from
systematically identiﬁed and extracted data from around the
world on both urinary and dietary Na, including many sources
with previously unavailable data and showing a good agree-
ment between the two metrics, as well as data from the Food
Balance Sheets of the Food and Agriculture Organization of the
United Nations(24), which captures the annual availability of
food for human consumption on the basis of reported local
production, imports and exports, at a country level. However,
primary data sources were limited or missing in many countries,
and the model reported by Powles et al.(12) used information
from neighbouring countries, taking into account similarities in
country-level covariates. According to the 95% uncertainty
intervals computed for Na intake in each country, precision
decreases from very high to low-HDI countries, which may
have contributed to inaccuracies in the country-speciﬁc PAF
estimates. However, given the marked differences between
these two levels of HDI, with very high presenting a median
PAF that is double of the one observed in low-HDI countries,
little effect may arise even if underestimation may be occurring
in low-HDI settings and overestimation may be found in the
very high settings. In addition, this is unlikely to compromise
the deﬁnition of general patterns, particularly with respect to
differences across sexes and between 2010 and 2030.
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Fig. 3. Estimates of population attributable fractions (PAF) for gastric cancer in 2010 ( ) and 2030 ( ) as a result of sodium intake above the WHO recommendation
(≤2g/d) in 187 countries by sex in 1990 and 2010, respectively, according to Human Development Index (HDI) in 2010. In each group of countries, the white line
represents the median, the box represents the interquartile range (IQR), the upper and lower limits represent values up to 1·5 times the IQR and the dots represent
outliers of the PAF distribution, respectively. HDI distribution in 2010 was retrieved from the Human Development Report, 2010(18): forty, forty-three, forty-three and
forty-two countries were classified as very high, high, medium and low HDI, respectively, and no evaluation was available for nineteen countries: Antigua and Barbuda,
Bhutan, Cuba, Dominica, Eritrea, Grenada, Iraq, Kiribati, North Korea, Lebanon, Marshall Islands, Oman, Palestine, Saint Lucia, Saint Vincent and the Grenadines,
Samoa, Seychelles, Somalia, Vanuatu.
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Gastric cancer is currently interpreted as a multifactorial
complex disease, and therefore different sets of causal
mechanisms leading to its occurrence may coexist(25). Under
this assumption, the same exposure (e.g. Na intake) may con-
tribute to the incidence of gastric cancer when occurring
together with different sets of other exposures (e.g. H. pylori
infection or H. pylori infection and fruit consumption or
H. pylori infection and smoking). Although the different causal
mechanisms potentially leading to gastric cancer are not
known, the estimated PAF reﬂect a scenario where Na intake is
within the range recommended by the WHO, and therefore
affecting all of the possible pathways to cancer, regardless of
the remaining exposures that take part in those causal
mechanisms. Therefore, our results provide information on the
importance of Na as a cause of gastric cancer, and show how
improvements in Na-reduction strategies may gradually con-
tribute to decrease the burden of gastric cancer.
In conclusion, high Na intake accounts for a large proportion
of gastric cancer cases, and this proportion is expected to
increase in the next few decades in almost all countries. Inten-
siﬁed efforts to reduce Na intake in virtually all populations are
needed to further decrease the burden of gastric cancer.
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